House Lawmaker Raises New Concerns Over FDA's Ultra-Fast Drug Review Program

(MedPage Today) — A Democratic lawmaker is raising new concerns about an FDA program designed to drastically shorten the review of certain drugs, including whether senior officials involved in the effort are complying with federal ethics rules…

Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/119721

Author :

Publish date : 2026-02-03 21:42:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

House Lawmaker Raises New Concerns Over FDA’s Ultra-Fast Drug Review Program

An Inside Look at the Measles Response in South Carolina

NIH Chief Details Plans for FDA Modernization at Senate Hearing

Related Posts

GLP-1 Pill Showdown; $35 Insulin Cap Success; Preterm Births Tied to Plastics

Measles Outbreak Kills Over 100 Kids in Bangladesh in a Month

Alzheimer’s-Autism Links; Early-Onset Dementia Risks; CAR-T for MS?

Cardiologist Sues UPMC; BP Control in a Rut; GLP-1 Drugs During Pregnancy

Cheltenham A&E service becomes minor injuries unit during strike

Here Are the Top Graduate Nursing Schools for 2026

GLP-1 Pill Showdown; $35 Insulin Cap Success; Preterm Births Tied to Plastics

Measles Outbreak Kills Over 100 Kids in Bangladesh in a Month

Alzheimer’s-Autism Links; Early-Onset Dementia Risks; CAR-T for MS?

Cardiologist Sues UPMC; BP Control in a Rut; GLP-1 Drugs During Pregnancy

Cheltenham A&E service becomes minor injuries unit during strike

Here Are the Top Graduate Nursing Schools for 2026

Mental Ill Health Drives Nurse Exit Risk Despite Workforce Growth

Study Flags Gaps in PrEP Use Among Youth at Risk for HIV

Categories

Archives